Bayer CEO Injects a Dose of U.S. Risk-Taking

Bayer’s CEO, Marijn Dekkers, is preparing to spin off the company’s $10 billion specialty-plastics business, part of an effort to refocus the company on health care and agriculture.

Speak Your Mind

Subscribe to get this amazing EBOOK FREE

Real Estate 101 - Buying Your First Home!

By subscribing to this newsletter you agree to our Privacy Policy